Cargando…

B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice

BACKGROUND: Human relaxin‐2 is a peptide hormone capable of pleiotropic effects in several organ systems. Its recombinant formulation (serelaxin) has been demonstrated to reduce infarct size and prevent excessive scar formation in animal models of cardiac ischemia‐reperfusion injury. B7‐33, a synthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Devarakonda, Teja, Mauro, Adolfo G., Guzman, Geronimo, Hovsepian, Sahak, Cain, Chad, Das, Anindita, Praveen, Praveen, Hossain, Mohammed Akhter, Salloum, Fadi N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428518/
https://www.ncbi.nlm.nih.gov/pubmed/32295457
http://dx.doi.org/10.1161/JAHA.119.015748
_version_ 1783571090793037824
author Devarakonda, Teja
Mauro, Adolfo G.
Guzman, Geronimo
Hovsepian, Sahak
Cain, Chad
Das, Anindita
Praveen, Praveen
Hossain, Mohammed Akhter
Salloum, Fadi N.
author_facet Devarakonda, Teja
Mauro, Adolfo G.
Guzman, Geronimo
Hovsepian, Sahak
Cain, Chad
Das, Anindita
Praveen, Praveen
Hossain, Mohammed Akhter
Salloum, Fadi N.
author_sort Devarakonda, Teja
collection PubMed
description BACKGROUND: Human relaxin‐2 is a peptide hormone capable of pleiotropic effects in several organ systems. Its recombinant formulation (serelaxin) has been demonstrated to reduce infarct size and prevent excessive scar formation in animal models of cardiac ischemia‐reperfusion injury. B7‐33, a synthetically designed peptide analogous to B‐chain of relaxin‐2, invokes signaling at relaxin family peptide receptor 1 (cognate receptor for relaxin‐2) by preferentially phosphorylating the mitogen‐activated protein kinase extracellular signal‐regulated kinase 1/2. We sought to investigate the effects of B7‐33 treatment post ischemia‐reperfusion injury in mice. METHODS AND RESULTS: Adult male CD1 mice were subjected to ischemia‐reperfusion via ligation of left anterior descending artery for 30 minutes, followed by 24 hours or 7 days of reperfusion. Echocardiography was performed to assess cardiac function, and cardiac tissue was stained to determine infarct size at 24 hours. B7‐33 significantly reduced infarct size (21.99% versus 45.32%; P=0.02) and preserved fractional shortening (29% versus 23%; P=0.02) compared with vehicle. The difference in fractional shortening further increased at 7 days post myocardial infarction (29% versus 20% for B7‐33 and vehicle groups, respectively). In vitro, primary cardiomyocytes were isolated from adult hearts and subjected to simulated ischemia‐reperfusion injury (simulated ischemia reoxygenation). B7‐33 (50 and 100 nmol/L) improved cell survival and reduced the expression of GRP78 (glucose regulated protein), an endoplasmic reticulum stress marker. Subsequently, B7‐33 (100 nmol/L) reduced tunicamycin (2.5 μg/mL) induced upregulation of GRP78 in an extracellular signal‐regulated kinase 1/2–dependent manner. CONCLUSIONS: B7‐33 confers acute cardioprotection and limits myocardial infarction–related adverse remodeling in mice by attenuating cardiomyocyte death and endoplasmic reticulum stress as well as preserving cardiac function.
format Online
Article
Text
id pubmed-7428518
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74285182020-08-17 B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice Devarakonda, Teja Mauro, Adolfo G. Guzman, Geronimo Hovsepian, Sahak Cain, Chad Das, Anindita Praveen, Praveen Hossain, Mohammed Akhter Salloum, Fadi N. J Am Heart Assoc Original Research BACKGROUND: Human relaxin‐2 is a peptide hormone capable of pleiotropic effects in several organ systems. Its recombinant formulation (serelaxin) has been demonstrated to reduce infarct size and prevent excessive scar formation in animal models of cardiac ischemia‐reperfusion injury. B7‐33, a synthetically designed peptide analogous to B‐chain of relaxin‐2, invokes signaling at relaxin family peptide receptor 1 (cognate receptor for relaxin‐2) by preferentially phosphorylating the mitogen‐activated protein kinase extracellular signal‐regulated kinase 1/2. We sought to investigate the effects of B7‐33 treatment post ischemia‐reperfusion injury in mice. METHODS AND RESULTS: Adult male CD1 mice were subjected to ischemia‐reperfusion via ligation of left anterior descending artery for 30 minutes, followed by 24 hours or 7 days of reperfusion. Echocardiography was performed to assess cardiac function, and cardiac tissue was stained to determine infarct size at 24 hours. B7‐33 significantly reduced infarct size (21.99% versus 45.32%; P=0.02) and preserved fractional shortening (29% versus 23%; P=0.02) compared with vehicle. The difference in fractional shortening further increased at 7 days post myocardial infarction (29% versus 20% for B7‐33 and vehicle groups, respectively). In vitro, primary cardiomyocytes were isolated from adult hearts and subjected to simulated ischemia‐reperfusion injury (simulated ischemia reoxygenation). B7‐33 (50 and 100 nmol/L) improved cell survival and reduced the expression of GRP78 (glucose regulated protein), an endoplasmic reticulum stress marker. Subsequently, B7‐33 (100 nmol/L) reduced tunicamycin (2.5 μg/mL) induced upregulation of GRP78 in an extracellular signal‐regulated kinase 1/2–dependent manner. CONCLUSIONS: B7‐33 confers acute cardioprotection and limits myocardial infarction–related adverse remodeling in mice by attenuating cardiomyocyte death and endoplasmic reticulum stress as well as preserving cardiac function. John Wiley and Sons Inc. 2020-04-16 /pmc/articles/PMC7428518/ /pubmed/32295457 http://dx.doi.org/10.1161/JAHA.119.015748 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Devarakonda, Teja
Mauro, Adolfo G.
Guzman, Geronimo
Hovsepian, Sahak
Cain, Chad
Das, Anindita
Praveen, Praveen
Hossain, Mohammed Akhter
Salloum, Fadi N.
B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
title B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
title_full B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
title_fullStr B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
title_full_unstemmed B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
title_short B7‐33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction–Related Adverse Cardiac Remodeling in Mice
title_sort b7‐33, a functionally selective relaxin receptor 1 agonist, attenuates myocardial infarction–related adverse cardiac remodeling in mice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428518/
https://www.ncbi.nlm.nih.gov/pubmed/32295457
http://dx.doi.org/10.1161/JAHA.119.015748
work_keys_str_mv AT devarakondateja b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice
AT mauroadolfog b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice
AT guzmangeronimo b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice
AT hovsepiansahak b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice
AT cainchad b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice
AT dasanindita b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice
AT praveenpraveen b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice
AT hossainmohammedakhter b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice
AT salloumfadin b733afunctionallyselectiverelaxinreceptor1agonistattenuatesmyocardialinfarctionrelatedadversecardiacremodelinginmice